Simó Schwartz Jr.

Dr. Simó Schwartz Jr.

Biochemistry and Molecular Biology Research Center for Nanomedicine (CIBBIM-Nanomedicine), University Hospital of Vall d’Hebron, Passeig Vall d’Hebron 119-129, Barcelona 08035, Spain
orcid

Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 May 2012 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
STStephan P Tenbaum
Stephan P Tenbaum
POPaloma Ordóñez-Morán
Paloma Ordóñez-Morán
IPIsabel Puig
Isabel Puig
ICIrene Chicote
Irene Chicote
OAOriol Arqués
Oriol Arqués
HPHéctor G Palmer
Héctor G Palmer

15 February 2009 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
SMSonia A Melo
Sonia A Melo
SRSantiago Ropero
Santiago Ropero
CMCatia Moutinho
Catia Moutinho
LALauri A Aaltonen
Lauri A Aaltonen
HYHiroyuki Yamamoto
Hiroyuki Yamamoto
MEManel Esteller
Manel Esteller

1 October 2010 in Cancer Cell
Verified
Journal Article
Closed access
Sónia A. MeloSónia A. Melo
Sónia A. Melo
CMCatia Moutinho
Catia Moutinho
SRSantiago Ropero
Santiago Ropero
George CalinGeorge Calin
George Calin
SRSimona Rossi
Simona Rossi
MEManel Esteller
Manel Esteller

1 July 2005 in European Journal of Cancer
Verified
Journal Article
Closed access
Sérgia VelhoSérgia Velho
Sérgia Velho
COCarla Oliveira
Carla Oliveira
AFAna Ferreira
Ana Ferreira
AFAntónio Carlos Ferreira
António Carlos Ferreira
GSGianpaolo Suriano
Gianpaolo Suriano
Raquel SerucaRaquel Seruca
Raquel Seruca

16 April 2006 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
SRSantiago Ropero
Santiago Ropero
MFMario Fdez. Fraga
Mario Fdez. Fraga
EBEsteban Ballestar
Esteban Ballestar
RHRichard Hamelin
Richard Hamelin
HYHiroyuki Yamamoto
Hiroyuki Yamamoto
MEManel Esteller
Manel Esteller

9 March 2021 in Cancers
Verified
Journal Article
Open access
PDF file
FAFernanda da Silva Andrade
Fernanda da Silva Andrade
MRMaria Mercé Roca-Melendres
Maria Mercé Roca-Melendres
Esteban Durán-LaraEsteban Durán-Lara
Esteban Durán-Lara
Diana RafaelDiana Rafael
Diana Rafael
Simó Schwartz Jr.Simó Schwartz Jr.
Simó Schwartz Jr.
Cancer remains as the second leading cause of death, worldwide. Despite the enormous important advances observed in the last decades, advanced stages of the disease remain incurable. The severe side effects associated to systemic high doses of chemotherapy and the development of drug resistance impairs a safe and efficiency anticancer therapy. Therefore, new formulations are continuously under research and development to improve anticancer drugs therapeutic index through localized delivery at tumor sites. Among a wide range of possibilities, hydrogels have recently gained special attention due to their potential to allow in situ sustained and controlled anticancer drug release. In particular, stimuli-responsive hydrogels which are able to change their physical state from liquid to gel accordingly to external factors such as temperature, pH, light, ionic strength, and magnetic field, among others. Some of these formulations presented promising results for the localized control and treatment of cancer. The present work aims to discuss the main properties and application of stimuli-responsive hydrogels in cancer treatment and summarize the most important advances observed in the last decades focusing on the use of pH-, light-, ionic strength-, and magnetic-responsive hydrogels.